OKYO Pharma Limited Overview

OKYO Pharma Limited Selling, General & Admin

Selling, General & Admin expenses for OKYO.

Quarterly SG&A Expenses

$2.84M

As of Sep 30, 2025

Annual SG&A Expenses (TTM)

$6.98M

↑ 137.08% YoY

Trailing 12 months ending Sep 30, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin